PTC Therapeutics, Inc. (NASDAQ:PTCT) Financings

PTC Therapeutics, Inc.

Financings

RaiseDate
0% Convertible Senior Notes due 2031
Update: US$500M
Use of proceeds: About $328.8 million to repurchase 2026 convertible notes; rest for general corporate purposes, including further repurchases or repayment of 2026 notes
Jun 16, 2026

Read by 6ix AI from the company's releases